πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 50 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 8492347

Peptide for induction of immune tolerance as treatment for systemic lupus erythematosus

The Regents of the University of California Β· Granted Tue Jul 23 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 18 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8440202

Induction of an immune response against dengue virus using the prime-boost approach

United States of America as represented by the Secretary of the Air Force Β· Granted Tue May 14 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 09 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8404244

Papillomavirus L2 N-terminal peptides for the induction of broadly cross-neutralizing anti

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Mar 26 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 21 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8241638

Induction of an immune response against dengue virus using the prime-boost approach

United States of America as represented by the Secretary of the Air Force Β· Granted Tue Aug 14 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 09 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8193225

Isoxazole amides, derivatives and methods of chemical induction of neurogenesis

The Board of Regents of the University of Texas System Β· Granted Tue Jun 05 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 31 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8163709

TAK1-D mediated induction of cell death in human cancer cells by specific sequence short d

The Board of Regents of the University of Texas System Β· Granted Tue Apr 24 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7875450

Virus-like particles for the induction of autoantibodies

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Jan 25 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 20 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7867974

Induction of tolerance by oral administration of factor VIII and treatment of hemophilia

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Jan 11 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 06 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7759313

Induction method for cell differentiation

OBSCHESTVO S OGRANICHENNOI OTVETSTVENNOSTIYU β€œPHARMENTERPRISES” Β· Granted Tue Jul 20 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 15 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7547759

Induction of tumor immunity by variants of folate binding protein

The Board of Regents of the University of Texas System Β· Granted Tue Jun 16 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 11 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7479280

Virus-like particles for the induction of autoantibodies

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Jan 20 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 15 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7326570

Induction of tubular morphogenesis using pleiotrophin

The Regents of the University of California Β· Granted Tue Feb 05 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 31 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7306804

HIV-specific T-cell induction

The Board of Regents of the University of Texas System Β· Granted Tue Dec 11 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 06 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7276352

Induction of Ξ² cell differentiation in human cells by stimulation of the GLP-1 receptor

The Regents of the University of California Β· Granted Tue Oct 02 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 27 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7176179

Selective induction of cell death by delivery of amino-terminal interleukin-1-Ξ± pro-piece

The Regents of the University of California Β· Granted Tue Feb 13 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 08 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 6911324

Induction of beta cell differentiation in human cells

The Regents of the University of California Β· Granted Tue Jun 28 2005 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 23 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6884585

Induction of beta cell differentiation in human cells by stimulation of the GLP-1 receptor

The Regents of the University of California Β· Granted Tue Apr 26 2005 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 21 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6884413

Induction of antigen-specific unresponsiveness by glioblastoma culture supernatants (GCS)

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Apr 26 2005 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 21 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6872385

Adjuvant preparation for the induction of specific immunity

The Board of Regents of the University of Texas System Β· Granted Tue Mar 29 2005 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 24 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6737052

Induction of programmed cell death by N5 gene

The Board of Regents of the University of Texas System Β· Granted Tue May 18 2004 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 13 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6719978

Virus-like particles for the induction of autoantibodies

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Apr 13 2004 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 08 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6685626

Compositions, devices, methods, and kits for induction of adhesions

Regeneration Technologies, Inc. Β· Granted Tue Feb 03 2004 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 29 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6656471

HIV-specific T-cell induction

The Board of Regents of the University of Texas System Β· Granted Tue Dec 02 2003 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 27 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6498189

Method for induction of L-selectin shedding

The Regents of the University of New Mexico Β· Granted Tue Dec 24 2002 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 19 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired